Method, device and medium for displaying molecular conformation

By providing molecular conformation display methods and devices in drug research and development, the problem of cumbersome molecular conformation screening process in drug research and development is solved, and convenient and intuitive conformation screening results are realized, which shortens the new drug development process and reduces the risk of failure.

CN117912601BActive Publication Date: 2024-11-01SUZHOU TENGMAI PHARM TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410114761.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-01-26
Publication Date
2024-11-01
Estimated Expiration
2044-01-26

AI Technical Summary

Technical Problem

During drug development, when performing molecular conformation screening in wet laboratories, the existing technology requires the design and synthesis of a large number of molecules, and through multiple conformation screenings to analyze the conformation of the drug ligand to be selected, resulting in large resource consumption and cumbersome process. Lack of convenient, intuitive and quick display methods.

Method used

Provide a molecular conformation display method and device, which highlights the display of the sensor by performing conformation screening of multiple ligands when detecting the trigger operation of the activation control, and displays the result interface based on the screening results, including a ligand list and a three-dimensional structural diagram. The default conformation and relative positional relationship between the body and the ligand can be obtained through simple operations to quickly screen out more preferred ligands to be selected for drug.

Benefits of technology

This greatly shortens the process of new drug development, reduces the risk of new drug failure, and improves the flexibility and efficiency of conformational screening. Users can easily and intuitively obtain conformational screening results, reducing resource consumption.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117912601B_ABST
    Figure CN117912601B_ABST
Patent Text Reader

Abstract

The present disclosure relates to a method, device and medium for displaying molecular conformations. The display method includes, when a trigger operation of a start control for a target project is detected, conformational screening of multiple ligands for a target project is performed to obtain screening results for multiple ligands; a result interface is displayed based on the screening results for multiple ligands; when a second ligand different from the first ligand is determined from a ligand list according to a ligand selection operation, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram. The method, device and medium for displaying molecular conformations according to the embodiments of the present disclosure enable users to obtain the results of conformational screening conveniently, intuitively and quickly through simple operations.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to the technical field of drug development, and in particular to a method, device and medium for displaying molecular conformations. Background Art

[0002] In related technologies, the wet lab drug discovery model requires the design and synthesis of a large number of molecules and preclinical studies. This is a process of trial and error and is only a qualitative study. In this process, a large amount of resources will be consumed for multiple conformational screenings to further analyze the conditions of the candidate ligands for each drug at the molecular conformation level.

[0003] Therefore, how to conveniently, intuitively and rapidly display the results of conformational screening is a technical problem that needs to be solved urgently. Summary of the invention

[0004] In view of this, the present disclosure proposes a method, device and medium for displaying molecular conformations, so that users can obtain the results of conformation screening conveniently, intuitively and quickly through simple operations.

[0005] According to one aspect of the present disclosure, a method for displaying molecular conformations is provided, comprising: in the case of detecting a trigger operation of a start control for a target item, performing conformational screening of multiple ligands for the target item to obtain screening results for the multiple ligands, the screening results including multiple molecular conformations; displaying a result interface based on the screening results for the multiple ligands, the result interface displaying a ligand list and a three-dimensional structure diagram, the ligand list displaying the multiple ligands, the three-dimensional structure diagram displaying a receptor, a default display conformation of a first ligand, and a relative position relationship between the receptor and the default display conformation of the first ligand, wherein the first ligand is a ligand that is highlighted among the multiple ligands displayed in the ligand list; in the case of determining a second ligand different from the first ligand from the ligand list according to a ligand selection operation, adding the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand to the three-dimensional structure diagram.

[0006] In this way, by detecting the trigger operation of the start control for the target project, the conformation screening of multiple ligands for the target project is performed to obtain the screening results for the multiple ligands, and the result interface is displayed based on the screening results for the multiple ligands, so that when a second ligand different from the first ligand is determined from the ligand list according to the ligand selection operation, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram, wherein the screening results include multiple molecular conformations, the result interface displays a ligand list and a three-dimensional structure diagram, the ligand list displays multiple ligands, and the three-dimensional structure diagram displays There are default displayed conformations of the receptor and the first ligand, and the relative position relationship between the default displayed conformations of the receptor and the first ligand, wherein the first ligand is a ligand that is prominently displayed among multiple ligands displayed in the ligand list. In this way, during the entire conformational screening process, the user needs to perform fewer and simpler operations, and can obtain the conformational screening results conveniently, intuitively and quickly through simple operations, which is convenient for users to view the conformation of the ligand and the relative position relationship between the conformation of the receptor and the ligand according to the result interface, and helps users to check the position of the ligand binding to the receptor according to the content displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0007] In one possible implementation, the method further includes: when a trigger operation for a conformational screening control is detected, displaying an initial interface for conformational screening, wherein at least one optional item is displayed in the initial interface; when the target item is determined from the at least one optional item according to an item selection operation, displaying a calculation input prompt for the target item, wherein the calculation input prompt displays a plurality of first input boxes and the start control, and different first input boxes are used to input different calculation inputs, wherein the calculation input includes at least one of a structure file recording a description of the ligand and screening data used for screening; based on the detected input operation for each of the calculation input boxes, displaying the determined calculation input for the target item in the calculation input prompt, so as to perform the conformational screening based on the calculation input when the start control is triggered.

[0008] In this way, the target project is determined through the project selection operation, and the calculation input for the target project is determined according to the calculation input prompt, so that conformational screening can be performed based on the calculation input when the start control is triggered. In this process, the user can not only flexibly select the target project from multiple optional projects, but also select any number of ligands in the target project for subsequent conformational screening, and can customize the calculation input to determine the data used for conformational screening, so as to obtain screening results that meet user needs, which greatly improves the flexibility of conformational screening and meets the user's conformational screening needs to the greatest extent.

[0009] In one possible implementation, the method further includes: in case of detecting a trigger operation on an input editing control displayed in the result interface, displaying an optional input prompt for the target item, wherein a plurality of second input boxes and the start control are displayed in the optional input prompt, and different second input boxes are used to enter different optional inputs, and the optional inputs include at least one of general data used for the conformational screening, molecule preparation data, molecular conformation generation data, molecule alignment data, grid generation data, molecular alignment scoring data, and result analysis data; based on the detected input operation on each of the second input boxes, displaying the determined optional input for the target item in the optional input prompt, so that the conformational screening can be performed based on the calculated input and the optional input when the start control is triggered.

[0010] In this way, the optional input prompt is displayed by triggering the input editing control, and the optional input for the target item is determined according to the calculation input prompt, so that when the start control is triggered, further conformational screening can be performed based on the calculation input and the optional input, thereby meeting the user's desire to make minor adjustments to the calculation data without having to start the entire conformational screening from scratch, which helps save computing resources while improving the flexibility of conformational screening.

[0011] In a possible implementation, the general data includes a calculation mode used for molecular docking, and / or the molecular preparation data includes at least one of data indicating a prefix of a ligand name and data indicating a method of using the ligand, and / or the molecular conformation generation data includes at least one of the number of molecular conformations created, an energy threshold of the molecular conformation, data used to indicate stereo center information, and a root mean square threshold of the molecular conformation, and / or the molecular alignment data includes data indicating an alignment method of the molecular conformation, data indicating a method of searching for the largest common substructure, a timeout for searching for the largest common substructure, and data indicating the presence of hydrogen atoms in the largest common substructure. The molecular alignment scoring data comprises at least one of data representing hydrogen atom reading information, the number of generated molecular conformations, the distance between grid points, data representing the flexibility information of the receptor, and data representing the configuration information of the molecular alignment, and / or the result analysis data comprises data representing the calculation of the molecular standard error.

[0012] In this way, at least one of the general data, molecule preparation data, molecular conformation generation data, molecular alignment data, grid generation data, molecular alignment scoring data, and result analysis data can be customized in the form of switches, input boxes, selection boxes, etc., which can facilitate users to quickly set optional inputs.

[0013] In one possible implementation, the result interface includes a first area and a second area, the first area includes multiple sub-areas, each of the sub-areas displays a corresponding ligand and a conformation browsing control, and the second area displays the three-dimensional structure diagram. The method also includes: when a trigger operation for the conformation browsing control is detected, determining a third ligand corresponding to the conformation browsing control, and displaying a molecular conformation list for the third ligand based on the screening results for the third ligand, the molecular conformation list displays description information of each molecular conformation of the third ligand, and the description information includes at least one of a conformation name, a conformation score, and a conformation configuration.

[0014] In this way, by detecting the trigger operation for the conformation browsing control and determining the third ligand corresponding to the conformation browsing control, and displaying the molecular conformation list for the third ligand based on the screening results for the third ligand, the conformation screening results of the third ligand selected by the user can be displayed intuitively, making it convenient for the user to compare the positions of the binding of various conformations of the same ligand to the receptor according to the molecular conformation list displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0015] In a possible implementation, the method further includes: when a first molecular conformation is determined from the molecular conformation list according to a conformation selection operation, displaying the first molecular conformation and the relative position relationship between the receptor and the first molecular conformation in the three-dimensional structure diagram, wherein the first molecular conformation is one of the molecular conformations of the third ligand corresponding to the molecular conformation list.

[0016] In this way, by detecting the conformation selection operation, the conformation selected by the user in the molecular conformation list is displayed in the three-dimensional structure diagram, which is convenient for the user to intuitively view the relative position relationship between the conformation and the receptor, and can also compare the position differences of different conformations under the same ligand, which helps to select the conformation that meets the user's actual needs.

[0017] In a possible implementation, each of the sub-areas also displays a conformation display prompt of the corresponding ligand, and the conformation display prompt includes the total number of molecular conformations of the ligand and the number of molecular conformations displayed in the three-dimensional structure diagram. The method also includes: when it is detected that the number of molecular conformations of the same ligand displayed in the three-dimensional structure diagram has changed, updating the number of molecular conformations of the ligand displayed in the three-dimensional structure diagram, and highlighting the latest conformation display prompt in the sub-area corresponding to the ligand; and / or, each of the sub-areas also displays a screening status prompt of the corresponding ligand, and the screening status prompt has different first and second states, wherein the screening status prompt in the first state indicates that the ligand has completed the conformation screening, and the screening status prompt in the second state indicates that the ligand has not undergone the conformation screening; and / or, the molecular conformation list also displays a collection control for each molecular conformation, and the method also includes: when a trigger operation for the collection control is detected, using the molecular conformation corresponding to the collection control as the default display conformation of the corresponding ligand; and / or, The conformation list also displays a first sorting control and a second sorting control, and the method further includes: when a trigger operation for the first sorting control is detected, displaying each molecular conformation in the molecular conformation list in a first order, wherein the first order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from high to low; when a trigger operation for the second sorting control is detected, displaying each molecular conformation in the molecular conformation list in a second order, wherein the second order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from low to high; and / or, the method further includes: when an adjustment operation for a position in the receptor or the molecular conformation in the three-dimensional structure diagram is detected, displaying the three-dimensional structure diagram with the position as the center; and / or, when a rotation operation for the three-dimensional structure diagram is detected, rotating the three-dimensional structure diagram; and / or, when a zoom operation for the three-dimensional structure diagram is detected, enlarging or reducing the display size of the three-dimensional structure diagram.

[0018] In this way, when too many conformations are displayed in the three-dimensional structure diagram, it is difficult to determine the number of displayed conformations with the naked eye. The conformation display prompt can help users intuitively understand the number of currently displayed conformations; and / or, by setting the screening status prompt corresponding to each ligand, it is possible to intuitively distinguish the ligands that have completed the conformational screening from the ligands that have not completed the conformational screening, so that users can select suitable ligands for screening in the secondary conformational screening without re-screening all ligands of the entire target project, which helps to save computing resources while improving the flexibility of conformational screening; and / or, by setting the collection control, it is convenient for users to collect suitable ligands, which helps to quickly obtain the historically collected conformations when viewing the result interface next time; And / or, in this way, by setting the first sorting control and the second sorting control, the sorting of each molecular conformation can be quickly achieved to meet the browsing needs of the user, which is helpful for the user to screen out suitable molecular conformations and is simple to operate; and / or, when faced with a larger three-dimensional structure diagram, the structure that needs to be further viewed can be quickly positioned to the center of the display area through such adjustment operations, thereby facilitating the user to continue to enlarge the three-dimensional structure diagram to meet viewing needs; and / or, by detecting the rotation operation of the three-dimensional structure diagram, the user's need to rotate the three-dimensional structure diagram can be responded to in a timely manner; and / or, by detecting the zoom operation of the three-dimensional structure diagram, the user's need to zoom the three-dimensional structure diagram can be responded to in a timely manner.

[0019] According to another aspect of the present disclosure, a molecular conformation display device is provided, comprising: a conformation screening module, wherein the conformation screening module is configured to, when a trigger operation of a start control for a target item is detected, perform conformation screening of multiple ligands for the target item to obtain screening results for the multiple ligands, wherein the screening results include multiple molecular conformations; a first display module, wherein the first display module is configured to display a result interface based on the screening results for the multiple ligands, wherein the result interface displays a ligand list and a three-dimensional structure diagram, wherein the ligand list displays the multiple ligands, and the three-dimensional structure diagram displays the receptor, the first ligand, A default display conformation and a relative position relationship between the default display conformation of the receptor and the default display conformation of the first ligand, wherein the first ligand is a ligand that is prominently displayed among multiple ligands displayed in the ligand list; a second display module, wherein the second display module is configured to, when a second ligand different from the first ligand is determined from the ligand list according to a ligand selection operation, add a default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand to the three-dimensional structure diagram.

[0020] In this way, when the conformation screening module detects the triggering operation of the start control for the target project, conformation screening of multiple ligands for the target project is performed to obtain screening results for the multiple ligands, and the first display module displays the result interface based on the screening results for the multiple ligands, so that when the second display module determines a second ligand different from the first ligand from the ligand list according to the ligand selection operation, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram, wherein the screening results include multiple molecular conformations, and the result interface displays a ligand list and a three-dimensional structure diagram, and the ligand list displays multiple ligands, and the three-dimensional structure diagram shows the default display conformations of the receptor and the first ligand, as well as the relative position relationship between the default display conformations of the receptor and the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list. In this way, in the entire conformational screening process, the user needs to perform fewer and simpler operations, and can obtain the conformational screening results conveniently, intuitively and quickly through simple operations, which is convenient for users to view the conformation of the ligand and the relative position relationship between the conformation of the receptor and the ligand according to the result interface, and helps users to check the position of the ligand and the receptor binding according to the content displayed on the result interface, quickly screen out a more preferred ligand conformation, and then screen out a more preferred drug candidate ligand, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0021] In one possible implementation, the device also includes a first determination module, which is configured to: when a trigger operation for a conformational screening control is detected, display an initial interface for conformational screening, wherein at least one optional item is displayed in the initial interface; when the target item is determined from the at least one optional item according to an item selection operation, display a calculation input prompt for the target item, wherein the calculation input prompt displays multiple first input boxes and the start control, and different first input boxes are used to input different calculation inputs, wherein the calculation input includes at least one of a structure file that records and describes the ligand and screening data used for screening; based on the detected input operation for each of the calculation input boxes, display the determined calculation input for the target item in the calculation input prompt, so that the conformational screening can be performed based on the calculation input when the start control is triggered.

[0022] In this way, the target project is determined through the project selection operation, and the calculation input for the target project is determined according to the calculation input prompt, so that conformational screening can be performed based on the calculation input when the start control is triggered. In this process, the user can not only flexibly select the target project from multiple optional projects, but also select any number of ligands in the target project for subsequent conformational screening, and can customize the calculation input to determine the data used for conformational screening, so as to obtain screening results that meet user needs, which greatly improves the flexibility of conformational screening and meets the user's conformational screening needs to the greatest extent.

[0023] In one possible implementation, the device also includes a second determination module, which is configured to: when a trigger operation is detected for the input editing control displayed in the result interface, display an optional input prompt for the target item, wherein multiple second input boxes and the start control are displayed in the optional input prompt, and different second input boxes are used to enter different optional inputs, and the optional inputs include at least one of general data used for conformational screening, molecular preparation data, molecular conformation generation data, molecular alignment data, grid generation data, molecular alignment scoring data, and result analysis data; based on the detected input operation for each of the second input boxes, display the determined optional input for the target item in the optional input prompt, so that the conformational screening is performed based on the calculated input and the optional input when the start control is triggered.

[0024] In this way, the optional input prompt is displayed by triggering the input editing control, and the optional input for the target item is determined according to the calculation input prompt, so that when the start control is triggered, further conformational screening can be performed based on the calculation input and the optional input, thereby meeting the user's desire to make minor adjustments to the calculation data without having to start the entire conformational screening from scratch, which helps save computing resources while improving the flexibility of conformational screening.

[0025] In a possible implementation, the general data includes a calculation mode used for molecular docking, and / or the molecular preparation data includes at least one of data indicating a prefix of a ligand name and data indicating a method of using the ligand, and / or the molecular conformation generation data includes at least one of the number of molecular conformations created, an energy threshold of the molecular conformation, data used to indicate stereo center information, and a root mean square threshold of the molecular conformation, and / or the molecular alignment data includes data indicating an alignment method of the molecular conformation, data indicating a method of searching for the largest common substructure, a timeout for searching for the largest common substructure, and data indicating the presence of hydrogen atoms in the largest common substructure. The molecular alignment scoring data comprises at least one of data representing hydrogen reading information, the number of generated molecular conformations, the distance between grid points, data representing the flexibility information of the receptor, and data representing the configuration information of the molecular alignment, and / or the result analysis data comprises data representing the calculation of the molecular standard error.

[0026] In this way, at least one of the general data, molecule preparation data, molecular conformation generation data, molecular alignment data, grid generation data, molecular alignment scoring data, and result analysis data can be customized in the form of switches, input boxes, selection boxes, etc., which can facilitate users to quickly set optional inputs.

[0027] In one possible implementation, the result interface includes a first area and a second area, the first area includes multiple sub-areas, each of the sub-areas displays a corresponding ligand and a conformation browsing control, the second area displays the three-dimensional structure diagram, and the device also includes a third display module, and the third display module is configured to: when a trigger operation for the conformation browsing control is detected, determine the third ligand corresponding to the conformation browsing control, and display a molecular conformation list for the third ligand based on the screening results for the third ligand, the molecular conformation list displays description information of each molecular conformation of the third ligand, and the description information includes at least one of the conformation name, conformation score, and conformation configuration.

[0028] In this way, by detecting the trigger operation for the conformation browsing control and determining the third ligand corresponding to the conformation browsing control, and displaying the molecular conformation list for the third ligand based on the screening results for the third ligand, the conformation screening results of the third ligand selected by the user can be displayed intuitively, making it convenient for the user to compare the positions of the binding of various conformations of the same ligand to the receptor according to the molecular conformation list displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0029] In a possible implementation, the device also includes a fourth display module, which is configured to: when a first molecular conformation is determined from the molecular conformation list according to a conformation selection operation, display the first molecular conformation and the relative position relationship between the receptor and the first molecular conformation in the three-dimensional structure diagram, wherein the first molecular conformation is one of the molecular conformations of the third ligand corresponding to the molecular conformation list.

[0030] In this way, by detecting the conformation selection operation, the conformation selected by the user in the molecular conformation list is displayed in the three-dimensional structure diagram, which is convenient for the user to intuitively view the relative position relationship between the conformation and the receptor, and can also compare the position differences of different conformations under the same ligand, which helps to select the conformation that meets the user's actual needs.

[0031] In a possible implementation, each of the sub-regions further displays a conformation display prompt of the corresponding ligand, and the conformation display prompt includes the total number of molecular conformations of the ligand and the number of molecular conformations displayed in the three-dimensional structure diagram. The device further includes an updating module, which is configured to: when detecting that the number of molecular conformations of the same ligand displayed in the three-dimensional structure diagram has changed, update the number of molecular conformations of the ligand displayed in the three-dimensional structure diagram, and highlight the latest conformation display prompt in the sub-region corresponding to the ligand; and / or each of the sub-regions further displays a corresponding ligand. A screening status prompt, wherein the screening status prompt has different first and second states, wherein the screening status prompt in the first state indicates that the ligand has completed the conformational screening, and the screening status prompt in the second state indicates that the ligand has not undergone the conformational screening; and / or, the molecular conformation list also displays a collection control for each molecular conformation, and the device also includes a third determination module, and the third determination module is configured to: when a trigger operation for the collection control is detected, use the molecular conformation corresponding to the collection control as the default display conformation of the corresponding ligand; and / or, The molecular conformation list also displays a first sorting control and a second sorting control, and the device also includes a sorting module, which is configured to: when a trigger operation for the first sorting control is detected, display the molecular conformations in the molecular conformation list in a first order, wherein the first order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from high to low; when a trigger operation for the second sorting control is detected, display the molecular conformations in the molecular conformation list in a second order, wherein the second order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from low to high; and / or, the device also includes an adjustment module, which is configured to: when an adjustment operation for a position in the receptor or the molecular conformation in the three-dimensional structure diagram is detected, display the three-dimensional structure diagram with the position as the center; and / or, when a rotation operation for the three-dimensional structure diagram is detected, rotate the three-dimensional structure diagram; and / or, when a zoom operation for the three-dimensional structure diagram is detected, enlarge or reduce the display size of the three-dimensional structure diagram.

[0032] In this way, when too many conformations are displayed in the three-dimensional structure diagram, it is difficult to determine the number of displayed conformations with the naked eye. The conformation display prompt can help users intuitively understand the number of currently displayed conformations; and / or, by setting the screening status prompt corresponding to each ligand, it is possible to intuitively distinguish the ligands that have completed the conformational screening from the ligands that have not completed the conformational screening, so that users can select suitable ligands for screening in the secondary conformational screening without re-screening all ligands of the entire target project, which helps to save computing resources while improving the flexibility of conformational screening; and / or, by setting the collection control, it is convenient for users to collect suitable ligands, which helps to quickly obtain the historically collected conformations when viewing the result interface next time; And / or, in this way, by setting the first sorting control and the second sorting control, the sorting of each molecular conformation can be quickly achieved to meet the browsing needs of the user, which is helpful for the user to screen out suitable molecular conformations and is simple to operate; and / or, when faced with a larger three-dimensional structure diagram, the structure that needs to be further viewed can be quickly positioned to the center of the display area through such adjustment operations, thereby facilitating the user to continue to enlarge the three-dimensional structure diagram to meet viewing needs; and / or, by detecting the rotation operation of the three-dimensional structure diagram, the user's need to rotate the three-dimensional structure diagram can be responded to in a timely manner; and / or, by detecting the zoom operation of the three-dimensional structure diagram, the user's need to zoom the three-dimensional structure diagram can be responded to in a timely manner.

[0033] According to another aspect of the present disclosure, a molecular conformation display device is provided, comprising: a processor; a memory for storing processor executable instructions; wherein the processor is configured to implement the above-mentioned molecular conformation display method when executing the instructions stored in the memory.

[0034] According to another aspect of the present disclosure, a non-volatile computer-readable storage medium is provided, on which computer program instructions are stored, wherein the computer program instructions implement the above-mentioned molecular conformation display method when executed by a processor.

[0035] Further features and aspects of the present disclosure will become apparent from the following detailed description of exemplary embodiments with reference to the attached drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] The accompanying drawings, which are incorporated in and constitute a part of the specification, illustrate exemplary embodiments, features, and aspects of the disclosure and, together with the description, serve to explain the principles of the disclosure.

[0037] Figure 1 A flow chart showing a method for displaying a molecular conformation according to an embodiment of the present disclosure is shown.

[0038] Figures 2 to 13A schematic diagram showing an interface in a method for displaying a molecular conformation according to an embodiment of the present disclosure.

[0039] Fig.14 A block diagram showing a device for displaying molecular conformations according to an embodiment of the present disclosure.

[0040] Fig.15 A block diagram showing a method for performing a molecular conformation display according to an embodiment of the present disclosure is shown. DETAILED DESCRIPTION

[0041] Various exemplary embodiments, features and aspects of the present disclosure will be described in detail below with reference to the accompanying drawings. The same figure numbers in the accompanying drawings represent elements with the same or similar functions. Although various aspects of the embodiments are shown in the accompanying drawings, the drawings need not be drawn to scale unless otherwise specified. The special word "exemplary" here means "used as an example, embodiment or illustrative". Any embodiment described here as "exemplary" is not necessarily interpreted as being superior or better than other embodiments. In addition, in order to better illustrate the present disclosure, numerous specific details are given in the specific embodiments below. Those skilled in the art should understand that the present disclosure can also be implemented without certain specific details. In some instances, methods, means, components and circuits well known to those skilled in the art are not described in detail in order to highlight the main purpose of the present disclosure.

[0042] To solve the above technical problems, the embodiments of the present disclosure provide a method for displaying molecular conformations, which performs conformational screening of multiple ligands for a target project when a trigger operation of a start control for a target project is detected, obtains screening results for multiple ligands, and displays a result interface based on the screening results for multiple ligands, so that when a second ligand different from the first ligand is determined from a ligand list according to a ligand selection operation, a default display conformation of the second ligand, a relative position relationship between the default display conformation of the second ligand and the receptor, and a relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram, wherein the screening result includes multiple molecular conformations, the result interface displays a ligand list and a three-dimensional structure diagram, and the ligand list display There are multiple ligands, and the three-dimensional structure diagram shows the default display conformations of the receptor and the first ligand, as well as the relative position relationship between the default display conformations of the receptor and the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list. In this way, in the entire conformational screening process, the user needs to perform fewer and simpler operations, and can obtain the conformational screening results conveniently, intuitively and quickly through simple operations, which is convenient for users to view the conformation of the ligand and the relative position relationship between the conformation of the receptor and the ligand according to the result interface, and helps users to check the position of the ligand and the receptor binding according to the content displayed on the result interface, quickly screen out a more preferred ligand conformation, and then screen out a more preferred drug candidate ligand, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0043] Figure 1 A flow chart of a method for displaying a molecular conformation according to an embodiment of the present disclosure is shown. Figure 1 As shown, the method for displaying the molecular conformation may include the following steps S101 to S103.

[0044] Step S101 : when a trigger operation of a start control for a target project is detected, conformational screening of multiple ligands for the target project is performed to obtain screening results for the multiple ligands.

[0045] Step S102: displaying a result interface based on the screening results for multiple ligands.

[0046] Step S103, when a second ligand different from the first ligand is determined from the ligand list according to the ligand selection operation, a default display conformation of the second ligand, a relative position relationship between the default display conformation of the second ligand and the receptor, and a relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram.

[0047] Figure 2 and Figure 3Schematic diagram of the interface in the molecular force field display method provided according to the embodiment of the present disclosure. The screening results may include multiple molecular conformations. The result interface may display a ligand list and a three-dimensional structure diagram. Figure 2 As shown, the result interface I1 may include a first area A1 and a second area A2. The first area A1 displays a ligand list, and the second area A2 displays a three-dimensional structure diagram. The ligand list displays multiple ligands. Figure 2 As shown, the first region A1 may include multiple sub-regions B1, each sub-region B1 displays a ligand, and different sub-regions B1 display different ligands. The three-dimensional structure diagram displays the default display conformation of the receptor and the first ligand, and the relative position relationship between the default display conformation of the receptor and the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list. Figure 2 As shown, the ligand named "ejm_45" is the highlighted ligand in the current ligand list. This ligand is the first ligand. The three-dimensional structure diagram displayed in the second area A2 can display the receptor, the default display conformation of the first ligand, and the relative position relationship between the receptor and the default display conformation of the first ligand. Generally, the first ligand can be set as the reference ligand by default, or other ligands can be selected according to the actual needs of the user. This embodiment of the present disclosure does not limit this. After the second ligand is determined from the ligand list according to the ligand selection operation, the first ligand is selected as the reference ligand. Figure 3 In the case of a ligand named "ejm_47", Figure 3 As shown, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand can be added to the three-dimensional structure diagram that originally displays the receptor, the default display conformation of the first ligand, and the relative position relationship between the default display conformation of the receptor and the first ligand.

[0048] In this way, through step S101, when a trigger operation of a start control for a target project is detected, conformation screening of multiple ligands for the target project can be performed to obtain screening results for multiple ligands, and the screening results may include multiple molecular conformations. Through step S102, a result interface can be displayed based on the screening results for multiple ligands, and the result interface can display a ligand list and a three-dimensional structure diagram, the ligand list displays multiple ligands, and the three-dimensional structure diagram displays the default display conformations of the receptor and the first ligand, and the relative position relationship between the default display conformations of the receptor and the first ligand, wherein the first ligand is a ligand that is highlighted among the multiple ligands displayed in the ligand list, and through step S103, a second ligand that is different from the first ligand can be determined from the ligand list according to the ligand selection operation. In this case, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram. Therefore, in the entire conformational screening process, the user needs to perform fewer and simpler operations, and can obtain the conformational screening results conveniently, intuitively and quickly through simple operations, which is convenient for the user to view the conformation of the ligand and the relative position relationship between the receptor and the conformation of the ligand according to the result interface, and helps the user to check the position of the ligand and the receptor binding according to the content displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0049] Figure 4-Figure 13 A schematic diagram of an interface in a method for displaying a molecular conformation according to an embodiment of the present disclosure is shown. Figure 1-Figure 13 The method for displaying the molecular conformation provided in the embodiments of the present disclosure is schematically illustrated.

[0050] In a possible implementation, during the process of conformational screening, a homepage for conformational screening may be displayed. A conformational screening control may be provided in the homepage. In the process of displaying the homepage to the user, when a trigger operation for the conformational screening control is detected, an initial interface for conformational screening may be displayed. In the initial interface, at least one optional item may be displayed. In the process of displaying the initial interface to the user, a project selection operation may be detected. For example, the project selection operation may be a single-click operation, a double-click operation, or other targeted selection operations for a certain optional item, so that a target item can be determined based on the project selection operation. In this way, when a project selection operation is detected, a target item can be determined from at least one optional item. Among them, the homepage and the initial interface for conformational screening may be flexibly set according to actual needs, and the embodiments of the present disclosure do not limit this.

[0051] In one possible implementation, when the target project is determined from at least one optional project according to the project selection operation, each ligand that binds to the receptor in the target project can be displayed in the initial interface. For example, in a certain area of ​​the initial interface, relevant information of each ligand that binds to the receptor in the target project can be displayed, and the relevant information can be the structural formula and name of the ligand. In this way, it is convenient for users to select one or more ligands for conformational screening, thereby avoiding excessive use of computing resources. For the ligands that have been selected and completed the conformational screening, the screening status prompts of each ligand can be displayed during the display process of the subsequent result interface to distinguish between ligands that have completed the conformational screening and ligands that have not completed the conformational screening. This will not be expanded here, and will be described later.

[0052] In a possible implementation, when a target project is determined from at least one optional project according to a project selection operation, a calculation input prompt for the target project can be displayed. The calculation input prompt can be displayed in a certain area in the initial interface, or it can be displayed in the form of a pop-up dialog box. The embodiment of the present disclosure does not limit this. The user can set the position and form of the calculation input prompt according to actual needs and / or preferences. In the calculation input prompt, multiple first input boxes and start controls can be displayed. Different first input boxes are used to input different calculation inputs, and the calculation input may include but is not limited to recording the structural file describing the ligand and the screening data used for conformational screening. The start control can be used to start conformational screening when triggered. According to the input operation detected for each calculation input box, the calculation input determined for the target project can be displayed in the calculation input prompt, so that conformational screening can be performed based on the calculation input when the start control is triggered. Generally, a new conformational screening task can be implemented by conformational screening based on the calculation input, and the ligands targeted in the new conformational screening task can be selected partially or in full.

[0053] In this way, the target project is determined through the project selection operation, and the calculation input for the target project is determined according to the calculation input prompt, so that conformational screening can be performed based on the calculation input when the start control is triggered. In this process, the user can not only flexibly select the target project from multiple optional projects, but also select any number of ligands in the target project for subsequent conformational screening, and can customize the calculation input to determine the data used for conformational screening, so as to obtain screening results that meet user needs, which greatly improves the flexibility of conformational screening and meets the user's conformational screening needs to the greatest extent.

[0054] After creating a new conformational screening task based on the calculation input, you can display the result interface based on the calculation results. The displayed result interface can be set with input editing controls, such as Figure 4The input editing control (Editing Parameters) Q1 in the result interface I1 is shown. In a possible implementation, when a trigger operation for the input editing control displayed in the result interface is detected, an optional input prompt for the target item may be displayed, for example Figure 4 The optional input prompt (TandemPose) T1 in the result interface I1 is shown. Figure 4 As shown, the optional input prompt T1 may include a prompt area T2 showing a plurality of second input boxes and a start control (Submit) Q2. Different second input boxes can be used to input different optional inputs, and the optional inputs may include at least one of common data (common), molecular preparation data (ligands_prepare), molecular conformation generation data (gen_conformers), molecular alignment data (mcss_align), grid generation data (grid_generation), molecular alignment scoring data (docking), and result analysis data (analysis) used for conformation screening. The start control can be used to start conformation screening when triggered. According to the input operation detected for each second input box, the determined optional input for the target project is displayed in the optional input prompt, so that conformation screening is performed based on the calculated input and the optional input when the start control is triggered. In general, further conformation screening tasks can be achieved by conformation screening based on the calculated input and the optional input. After obtaining the screening results obtained based on the calculated input, further conformation screening using the optional input again can meet the user's minor adjustments to the needs without recalculating from the beginning, which greatly saves computing resources.

[0055] In this way, the optional input prompt is displayed by triggering the input editing control, and the optional input for the target item is determined according to the calculation input prompt, so that when the start control is triggered, further conformational screening can be performed based on the calculation input and the optional input, thereby meeting the user's desire to make minor adjustments to the calculation data without having to start the entire conformational screening from scratch, which helps save computing resources while improving the flexibility of conformational screening.

[0056] In a possible implementation, the common data (common) may include calculation modes used for molecular docking, such as dockcalc, freedock, and remove_receptor_H. An independent switch control with an on or off state may be set so that the user can set the calculation mode used for molecular docking by controlling the on and off of the switch control, for example Figure 5The switch control corresponding to dockcalc is in the on state, which means that the user chooses to turn on dockcalc for molecular docking. Similarly to dockcalc, you can also set corresponding switch controls with on or off states for freedock and remove_receptor_H, which will not be repeated here. In this way, the user can quickly set the common data in the optional input in the form of a switch. For example, if Figure 5 As shown, the switch control Q3 corresponding to remove_receptor_H is in the on state, which means that the user chooses to remove the hydrogen atoms in the receptor (protein) during molecular docking.

[0057] In a possible implementation, the molecule preparation data (ligands_prepare) may include at least one of data indicating a prefix of the ligand name (Prefix) and data indicating a method of using the ligand (method). An input box may be set for the data indicating a prefix of the ligand name (Prefix) to facilitate users to customize the prefix of the ligand name. An option box may be set for the data indicating a method of using the ligand (method) to determine which method of using the ligand (e.g., rdkit, obabel) to use for conformational screening. In this way, the user can quickly set the molecule preparation data in the optional input in the form of an input box or an option box. For example, if Figure 6 As shown, an input box can be set for data (method) representing the method of using the ligand, and options (rdkit, obabel) can be set for data (method) representing the method of using the ligand for the user to select. Figure 6 The option corresponding to obabel is highlighted, which means that conformational screening is performed under the premise that the ligand usage mode is obabel.

[0058] In a possible implementation, the generation data of the molecular conformation (gen_conformers) may include at least one of the number of molecular conformations created (confnum), the energy threshold of the molecular conformation (confenergymax), the data for representing the stereo center information (nostrictstereo), and the root mean square threshold (rms) of the molecular conformation. An input box may be set for the number of molecular conformations created (confnum) to facilitate the user to customize how many conformers the conformation screening task needs to create. An input box may be set for the energy threshold (confenergymax) of the molecular conformation to facilitate the user to customize the maximum energy value of the conformation. An independent switch control with an on or off state may be set for the data representing the stereo center information (nostrictstereo) to indicate whether the stereo center is required to be specified. An input box may be set for the root mean square threshold (rms) of the molecular conformation to facilitate the user to customize the minimum root mean square threshold of the generated conformation, so that the generated conformation needs to meet the minimum root mean square threshold before the conformation can be generated. In this way, the user can quickly set the generation data of the molecular conformation in the optional input in the form of an input box and a switch. For example, if Figure 7 As shown, the switch control Q4 can be set to nostrictstereo for this data. Figure 7 The switch control Q4 corresponding to nostrictstereo for this data is off, which means that conformational screening is performed without requiring the specification of stereocenters.

[0059] In a possible implementation, the molecular alignment data (mcss_align) may include at least one of data (method) representing the alignment method of the molecular conformation, data (mcs) representing the search method of the maximum common substructure, a timeout for searching the maximum common substructure, data (removeHs) representing the information of the presence of hydrogen atoms in the maximum common substructure, a threshold (threshold) for starting to search for the maximum common substructure, data (completeRingsOnly) representing the complete matching information of the ring, data (matchValences) representing the valence matching information, data (ringMatchesRingOnly) representing the matching information between rings, data (atomCompare) representing the atomic comparison method, and data (bondCompare) representing the chemical bond comparison method. An option box may be set for the data (method) representing the alignment method of the molecular conformation to determine which molecular conformation alignment method (e.g., rdkitmcs, pharmalign, shapealign) is used. An option box may be set for the data (mcs) representing the search method of the maximum common substructure to determine which method (e.g., pair-wise, combined) is used to search for the maximum common substructure. An input box can be set for the timeout for finding the largest common substructure (timeout) to facilitate users to customize the timeout for finding the largest common substructure. An independent switch control with an on or off state can be set for the data representing the information of the presence of hydrogen atoms in the largest common substructure (removeHs) to indicate whether to remove hydrogen atoms when finding the largest common substructure. An input box can be set for the threshold for starting to find the largest common substructure (threshold) to facilitate users to customize the threshold to successfully generate conformations. An independent switch control with an on or off state can be set for the data representing the complete matching information of the ring (completeRingsOnly) to indicate whether the ring on the complete match is required. An independent switch control with an on or off state can be set for the data representing the valence matching information (matchValences) to indicate whether to match the valence information. An independent switch control with an on or off state can be set for the data representing the matching information between rings (ringMatchesRingOnly) to indicate whether to let the rings match each other. You can set an option box for the data representing the atom comparison method (atomCompare) to determine which atom comparison method to use (e.g. CompareIsotopes, CompareElements).Option boxes can be set for data representing the chemical bond comparison method (bondCompare) to determine which chemical bond comparison method to use (e.g. CompareOrder, CompareOrderExact). In this way, users can quickly set the molecular alignment data in the optional input through input boxes, switches, and option boxes. For example, such as. Figure 8 As shown, the switch control Q5 can be set for the ringMatchesRingOnly data. Figure 8 The switch control Q5 corresponding to the ringMatchesRingOnly data is in the on state, which means that conformational screening is performed on the premise that the rings match each other.

[0060] In a possible implementation, the grid generation data (grid_generation) may include at least one of the distance between grid points (gridspace) and the grid generation method (site_mapper). An input box may be set for the distance between grid points (gridspace) to facilitate users to customize the distance between grid points. An option box may be set for the grid generation method (site_mapper) to determine which grid generation method (e.g., RbtSphereSiteMapper, RbtLigandSiteMapper) is used. In this way, the user can quickly set the grid generation data in the optional input in the form of an input box or an option box. For example, if Fig. 9 As shown, you can set an input box for the gridspace data to facilitate users to customize the distance between grid points, for example Fig. 9 In this input box, the value is 0.3, which means that during the conformational screening process, the generated grid satisfies the distance between grid points of 0.3.

[0061] In one possible implementation, the molecular alignment scoring data (docking) includes at least one of data representing hydrogen atom reading information (allH), the number of generated molecular conformations (numposes), the distance between grid points (gridspace), data representing receptor flexibility information (receptor_flex), and data representing molecular alignment configuration information (inter). An independent switch control with an on or off state can be set for the data representing hydrogen reading information (allH) to indicate whether all hydrogens are read. An input box can be set for the number of generated molecular conformations (numposes) to facilitate users to customize the number of generated conformations. An input box can be set for the distance between grid points (gridspace) to facilitate users to customize the distance between grid points. An option box can be set for the data representing receptor flexibility information (receptor_flex) to determine which value of the receptor flexibility value to select, for example Fig.10 The option box corresponding to receptor_flex is selected as 3.0, which means that the OH and NH3+ groups on the receptor are flexible within the scope of molecular docking. The option box for the data (inter) representing the configuration information of the molecular alignment can be set to determine which parameter file (e.g. RbtInterIdxSF.prm, RbtSolvIdxSF.prm) to use. For example, if Fig.10 As shown, an input box can be set for numposes to facilitate the user to customize the number of conformations to be generated, for example Fig.10 The number in this input box is 20, that is, 20 conformations are generated after conformational screening for each ligand.

[0062] In a possible implementation, the result analysis data (analysis) includes data indicating the calculation of the molecular standard error (rmsd). An independent switch control with an on or off state can be set for the data indicating the calculation of the molecular standard error (rmsd) to indicate whether to calculate the value of the molecular standard error. For example, Fig.11 As shown, the switch control Q6 can be set for the rmsd data to facilitate the user to customize whether to calculate the value of the molecular standard error, for example Fig.11 The switch control Q6 is in the off state, which means that the value of the numerator standard error is not calculated.

[0063] In a possible implementation, the optional input may further include custom data (Manual Poses). The custom data may include a file recording and describing a dataset ligand conformation (Dataset Ligand Poses) and a file of a reference ligand (Reference Ligand).

[0064] In the result interface, in addition to displaying the corresponding ligands, Fig.12 As shown, each sub-area B1 of the first area A1 also displays a conformation browsing control Q7. By triggering the conformation browsing control, the conformation list (Ligand Poses) of the ligand corresponding to the triggered conformation browsing control can be browsed.

[0065] In one possible implementation, in the process of displaying the result interface to the user, when a trigger operation for a conformation browsing control is detected, the third ligand corresponding to the conformation browsing control can be determined, and a molecular conformation list for the third ligand can be displayed based on the screening result for the third ligand. For example, the trigger operation for the conformation browsing control can be a single-click operation, a double-click operation, or other operations. The molecular conformation list can display description information for each molecular conformation of the third ligand, and the description information may include at least one of the conformation name (Pose), conformation score (Score), and conformation configuration (Source). Regardless of whether the currently triggered conformation browsing control is the ligand displayed in the current three-dimensional structure diagram, the conformation list of the ligand corresponding to the conformation browsing control can be displayed. In other words, the third ligand can be the first ligand or the second ligand, or it can be a ligand other than the first ligand and the second ligand. For example, if Fig.12 As shown, when the triggering operation of the conformation browsing control Q7 corresponding to the ligand with the ligand name "ejm_42" is detected, the conformation list of the ligand with the ligand name "ejm_42" can be displayed in the third area A3 of the result interface I1.

[0066] In this way, by detecting the trigger operation for the conformation browsing control and determining the third ligand corresponding to the conformation browsing control, and displaying the molecular conformation list for the third ligand based on the screening results for the third ligand, the conformation screening results of the third ligand selected by the user can be displayed intuitively, making it convenient for the user to compare the positions of the binding of various conformations of the same ligand to the receptor according to the molecular conformation list displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0067] In a possible implementation, during the display of the molecular conformation list, a conformation selection operation may be detected. When the first molecular conformation is determined from the molecular conformation list according to the conformation selection operation, the first molecular conformation and the relative position relationship between the receptor and the first molecular conformation may be displayed in the three-dimensional structure diagram. The first molecular conformation is one of the molecular conformations of the third ligand corresponding to the molecular conformation list. For example, Fig.12 As shown, when displaying the molecular conformation list corresponding to the ligand named "ejm_42" (i.e. Fig.13In the process of selecting "Ligand Poses-ejm_42" in the ligand, the first molecular conformation is determined to be the conformation named "pose16" according to the conformation selection operation, so that the relative position relationship between the first molecular conformation, the receptor and the first molecular conformation can be displayed in the three-dimensional structure diagram. The conformation named "pose20" of the ligand named "ejm_42" is already displayed in the three-dimensional structure diagram. Fig.13 In the case of the second molecular conformation, it can be Fig.12 The three-dimensional structure diagram shows the positional differences of the two conformations (the conformation named "pose20" and the conformation named "pose16"), which is convenient for users to compare and select a more suitable conformation. In this way, by detecting the conformation selection operation, the conformation selected by the user in the molecular conformation list is displayed in the three-dimensional structure diagram, which is convenient for users to intuitively view the relative positional relationship between the conformation and the receptor, and can also compare the positional differences of different conformations under the same ligand, which is helpful to select a conformation that meets the actual needs of users.

[0068] In the result interface, in addition to displaying the corresponding ligand and conformation browsing controls, such as Fig.12 As shown, each sub-area B1 of the first area A1 also displays a conformation display prompt Q8. The conformation display prompt may include the total number of molecular conformations of the ligand and the number of molecular conformations displayed in the three-dimensional structure diagram.

[0069] In a possible implementation, when it is detected that the number of molecular conformations of the same ligand displayed in the three-dimensional structure diagram has changed, the number of molecular conformations of the ligand displayed in the three-dimensional structure diagram can be updated, and the latest conformation display prompt can be highlighted in the sub-region corresponding to the ligand. For example, Fig.13 The three-dimensional structure diagram shown shows one molecular conformation (the second molecular conformation is the conformation named "pose20") of the third ligand (i.e., the ligand with the ligand name "ejm_42"). At this time, the conformation display prompt Q8 corresponding to the third ligand is "1 / 20", wherein "1" indicates that the number of molecular conformations of the third ligand displayed in the three-dimensional structure diagram is 1, and "20" indicates that the total number of conformations of the third ligand is 20. When the first molecular conformation (i.e., the conformation named "pose16") is determined from the molecular conformation list according to the conformation selection operation, the first molecular conformation and the relative position relationship between the receptor and the first molecular conformation can be displayed in the three-dimensional structure diagram. At this time, it can be detected that the number of molecular conformations of the third ligand displayed in the three-dimensional structure diagram has changed (i.e., from the original 1 to the current 2). In this case, the number of molecular conformations of the third ligand displayed in the three-dimensional structure diagram can be updated and the latest conformation display prompt can be highlighted in the sub-area corresponding to the third ligand, i.e. Fig.12The displayed conformation display prompt Q8 of the third ligand is "2 / 20", where "2" indicates that the number of molecular conformations of the third ligand displayed in the three-dimensional structure diagram is 2, and "20" indicates that the total number of conformations of the third ligand is 20. In this way, when too many conformations are displayed in the three-dimensional structure diagram, it is difficult to determine the number of displayed conformations with the naked eye, and the conformation display prompt can help users intuitively understand the number of currently displayed conformations.

[0070] In a possible implementation, in the result interface, in addition to displaying the corresponding ligand, conformation browsing controls, and conformation display prompts, such as Fig.12 As shown, each sub-area B1 of the first area A1 also displays a screening status prompt Q9 of the corresponding ligand. The screening status prompt may have different first and second states, wherein the screening status prompt in the first state indicates that the ligand has completed conformational screening, and the screening status prompt in the second state indicates that the ligand has not undergone conformational screening. For example, Fig.12 As shown, the screening status prompt Q9 corresponding to the third ligand that has completed conformational screening is in the first state, that is, the screening status prompt Q9 is highlighted green, while the screening status prompt corresponding to the ligand that has not completed conformational screening is in the first state (can be highlighted red, not shown). Among them, green highlighting and red highlighting are only for illustration, and the embodiments of the present disclosure are not limited to this. The user can set the form of presentation of the state according to actual needs and / or preferences to distinguish between the first state and the second state. In this way, by setting the screening status prompt corresponding to each ligand, it is possible to intuitively distinguish between ligands that have completed conformational screening and ligands that have not completed conformational screening, which is convenient for users to select suitable ligands for screening during secondary conformational screening without the need to re-screen all ligands of the entire target project, which helps to save computing resources while improving the flexibility of conformational screening.

[0071] like Fig.13 As shown, in the molecular conformation list displayed in the third area A3 of the result interface I1, a collection control Q10 for each molecular conformation may also be displayed (for example Fig.13 red five-pointed star in the middle).

[0072] In a possible implementation, when a trigger operation for a collection control is detected, the molecular conformation corresponding to the collection control can be used as the default display conformation of the corresponding ligand. The result interface can be refreshed immediately and the default display conformation can be displayed in the refreshed result interface, or the default display conformation can be displayed the next time the result interface is displayed. The disclosed embodiment does not limit this, and the user can set the refresh time according to actual needs and / or preferences. In this way, through the setting of the collection control, it is convenient for users to collect suitable ligands, which helps to quickly obtain the historical collection conformation when viewing the result interface next time.

[0073] The molecular conformation list may also be displayed with a first sorting control and a second sorting control. In a possible implementation, when a trigger operation for the first sorting control is detected, each molecular conformation in the molecular conformation list may be displayed in a first order, wherein the first order is a molecular conformation order determined by sorting all molecular conformations in the molecular conformation list from high to low. When a trigger operation for the second sorting control is detected, each molecular conformation in the molecular conformation list may be displayed in a second order, wherein the second order is a molecular conformation order determined by sorting all molecular conformations in the molecular conformation list from low to high. The basis for sorting may be the first letter of the name of each molecular conformation, or it may be a molecular conformation score, which is not limited in the disclosed embodiment. In this way, by setting the first sorting control and the second sorting control, the sorting of each molecular conformation can be quickly realized to meet the browsing needs of the user, which helps the user to screen out suitable molecular conformations, and the operation is simple.

[0074] In one possible implementation, when an adjustment operation is detected for a position in a receptor or a molecular conformation in a three-dimensional structure diagram, the three-dimensional structure diagram can be displayed with the position as the center. The adjustment operation can be a single-click operation, a double-click operation, or other operations with a positioning function, so that when an adjustment operation is detected for a position in a receptor or a molecular conformation in a three-dimensional structure diagram, the position pointed to by the adjustment operation is used as the center to display the three-dimensional structure diagram. In this way, when facing a larger three-dimensional structure diagram, the structure that needs to be further viewed can be quickly positioned to the center of the display area through such an adjustment operation, thereby facilitating the user to continue to zoom in on the three-dimensional structure diagram to meet viewing needs.

[0075] In a possible implementation, when a rotation operation on the three-dimensional structure diagram is detected, the three-dimensional structure diagram is rotated. The rotation operation may be an operation such as sliding the mouse after clicking on the three-dimensional structure diagram. Those skilled in the art may set the implementation method of the rotation operation according to actual needs and / or preferences, and the embodiments of the present disclosure do not limit this. In this way, by detecting the rotation operation on the three-dimensional structure diagram, the user's demand for rotating the three-dimensional structure diagram can be responded to in a timely manner.

[0076] In a possible implementation, when a zoom operation on the three-dimensional structure diagram is detected, the display size of the three-dimensional structure diagram is enlarged or reduced. The zoom operation may be an operation such as a scroll operation on a mouse wheel. Those skilled in the art may set the implementation method of the zoom operation according to actual needs and / or preferences, and the embodiments of the present disclosure do not limit this. In this way, by detecting the zoom operation on the three-dimensional structure diagram, the user's need to zoom the three-dimensional structure diagram can be responded to in a timely manner.

[0077] Fig.14A block diagram of a molecular conformation display device provided according to an embodiment of the present disclosure is shown. Fig.14 As shown, the molecular conformation display device 1400 may include: a conformation screening module 1401, wherein the conformation screening module 1401 is configured to perform conformation screening of multiple ligands for the target project when a trigger operation of a start control for the target project is detected, and obtain screening results for the multiple ligands, wherein the screening results include multiple molecular conformations; a first display module 1402, wherein the first display module 1402 is configured to display a result interface based on the screening results for the multiple ligands, wherein the result interface displays a ligand list and a three-dimensional structure diagram, wherein the ligand list displays the multiple ligands, and the three-dimensional structure diagram displays the receptor, the first ligand The default display conformation and the relative position relationship between the default display conformation of the receptor and the default display conformation of the first ligand, wherein the first ligand is a ligand that is prominently displayed among multiple ligands displayed in the ligand list; the second display module 1403, the second display module 1403 is configured to add the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand to the three-dimensional structure diagram when a second ligand different from the first ligand is determined from the ligand list according to a ligand selection operation.

[0078] In this way, when the conformation screening module detects the triggering operation of the start control for the target project, conformation screening of multiple ligands for the target project is performed to obtain screening results for the multiple ligands, and the first display module displays the result interface based on the screening results for the multiple ligands, so that when the second display module determines a second ligand different from the first ligand from the ligand list according to the ligand selection operation, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram, wherein the screening results include multiple molecular conformations, and the result interface displays a ligand list and a three-dimensional structure diagram, and the ligand list displays multiple ligands, and the three-dimensional structure diagram shows the default display conformations of the receptor and the first ligand, as well as the relative position relationship between the default display conformations of the receptor and the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list. In this way, in the entire conformational screening process, the user needs to perform fewer and simpler operations, and can obtain the conformational screening results conveniently, intuitively and quickly through simple operations, which is convenient for users to view the conformation of the ligand and the relative position relationship between the conformation of the receptor and the ligand according to the result interface, and helps users to check the position of the ligand and the receptor binding according to the content displayed on the result interface, quickly screen out a more preferred ligand conformation, and then screen out a more preferred drug candidate ligand, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0079] In one possible implementation, the device also includes a first determination module, which is configured to: when a trigger operation for a conformational screening control is detected, display an initial interface for conformational screening, wherein at least one optional item is displayed in the initial interface; when the target item is determined from the at least one optional item according to an item selection operation, display a calculation input prompt for the target item, wherein the calculation input prompt displays multiple first input boxes and the start control, and different first input boxes are used to input different calculation inputs, wherein the calculation input includes at least one of a structure file that records and describes the ligand and screening data used for screening; based on the detected input operation for each of the calculation input boxes, display the determined calculation input for the target item in the calculation input prompt, so that the conformational screening can be performed based on the calculation input when the start control is triggered. In this way, the target project is determined through the project selection operation, and the calculation input for the target project is determined according to the calculation input prompt, so that conformational screening can be performed based on the calculation input when the start control is triggered. In this process, the user can not only flexibly select the target project from multiple optional projects, but also select any number of ligands in the target project for subsequent conformational screening, and can customize the calculation input to determine the data used for conformational screening, so as to obtain screening results that meet user needs, which greatly improves the flexibility of conformational screening and meets the user's conformational screening needs to the greatest extent.

[0080] In a possible implementation, the device further includes a second determination module, which is configured to: display an optional input prompt for the target item when a trigger operation for the input editing control displayed in the result interface is detected, wherein the optional input prompt displays multiple second input boxes and the start control, and different second input boxes are used to input different optional inputs, wherein the optional inputs include at least one of the general data used for the conformational screening, molecule preparation data, molecular conformation generation data, molecule alignment data, grid generation data, molecular alignment scoring data, and result analysis data; display the determined optional input for the target item in the optional input prompt according to the input operation detected for each second input box, so as to perform the conformational screening based on the calculated input and the optional input when the start control is triggered. In this way, the optional input prompt is displayed by triggering the input editing control, and the optional input for the target item is determined according to the calculated input prompt, so as to achieve further conformational screening based on the calculated input and the optional input when the start control is triggered, thereby meeting the user's expectation of making minor adjustments to the calculated data, without having to start the entire conformational screening from scratch, and helping to save computing resources while improving the flexibility of conformational screening.

[0081] In a possible implementation, the general data includes a calculation mode used for molecular docking, and / or the molecular preparation data includes at least one of data indicating a prefix of a ligand name and data indicating a method of using the ligand, and / or the molecular conformation generation data includes at least one of the number of molecular conformations created, an energy threshold of the molecular conformation, data used to indicate stereo center information, and a root mean square threshold of the molecular conformation, and / or the molecular alignment data includes data indicating an alignment method of the molecular conformation, data indicating a method of searching for the largest common substructure, a timeout for searching for the largest common substructure, and data indicating the presence of hydrogen atoms in the largest common substructure. At least one of data, a threshold for starting to search for the largest common substructure, data indicating complete matching information of a ring, data indicating valence matching information, data indicating matching information between rings, data indicating a method for comparing atoms, and data indicating a method for comparing chemical bonds, and / or the grid generation data includes the distance between grid points, and / or the molecular alignment scoring data includes at least one of data indicating hydrogen reading information, the number of generated molecular conformations, the distance between grid points, data indicating flexible information of receptors, and data indicating configuration information for molecular alignment, and / or the result analysis data includes data indicating calculation of molecular standard errors. In this way, at least one of general data, molecular preparation data, molecular conformation generation data, molecular alignment data, grid generation data, molecular alignment scoring data, and result analysis data can be customized in the form of switches, input boxes, selection boxes, etc., which can facilitate users to quickly set optional inputs.

[0082] In one possible implementation, the result interface includes a first area and a second area, the first area includes multiple sub-areas, each of the sub-areas displays a corresponding ligand and a conformation browsing control, the second area displays the three-dimensional structure diagram, and the device also includes a third display module, and the third display module is configured to: when a trigger operation for the conformation browsing control is detected, determine the third ligand corresponding to the conformation browsing control, and display a molecular conformation list for the third ligand based on the screening results for the third ligand, the molecular conformation list displays description information of each molecular conformation of the third ligand, and the description information includes at least one of the conformation name, conformation score, and conformation configuration. In this way, by detecting the trigger operation for the conformation browsing control and determining the third ligand corresponding to the conformation browsing control, and displaying the molecular conformation list for the third ligand based on the screening results for the third ligand, the conformation screening results of the third ligand selected by the user can be displayed intuitively, making it convenient for the user to compare the positions of the binding of various conformations of the same ligand to the receptor according to the molecular conformation list displayed on the result interface, quickly screen out more preferred ligand conformations, and then screen out more preferred drug candidate ligands, greatly shortening the new drug development process and reducing the risk of new drug failure.

[0083] In a possible implementation, the device further includes a fourth display module, and the fourth display module is configured to: when a first molecular conformation is determined from the molecular conformation list according to the conformation selection operation, display the first molecular conformation and the relative positional relationship between the receptor and the first molecular conformation in the three-dimensional structure diagram, wherein the first molecular conformation is one of the molecular conformations of the third ligand corresponding to the molecular conformation list. In this way, by detecting the conformation selection operation, the conformation selected by the user in the molecular conformation list is displayed in the three-dimensional structure diagram, which facilitates the user to intuitively view the relevant positional relationship between the conformation and the receptor, and can also compare the positional differences of different conformations under the same ligand, which helps to select a conformation that meets the actual needs of the user.

[0084] In a possible implementation, each of the sub-regions further displays a conformation display prompt of the corresponding ligand, and the conformation display prompt includes the total number of molecular conformations of the ligand and the number of molecular conformations displayed in the three-dimensional structure diagram. The device further includes an updating module, which is configured to: when detecting that the number of molecular conformations of the same ligand displayed in the three-dimensional structure diagram has changed, update the number of molecular conformations of the ligand displayed in the three-dimensional structure diagram, and highlight the latest conformation display prompt in the sub-region corresponding to the ligand; and / or each of the sub-regions further displays a corresponding ligand. A screening status prompt, wherein the screening status prompt has different first and second states, wherein the screening status prompt in the first state indicates that the ligand has completed the conformational screening, and the screening status prompt in the second state indicates that the ligand has not undergone the conformational screening; and / or, the molecular conformation list also displays a collection control for each molecular conformation, and the device also includes a third determination module, and the third determination module is configured to: when a trigger operation for the collection control is detected, use the molecular conformation corresponding to the collection control as the default display conformation of the corresponding ligand; and / or, The molecular conformation list also displays a first sorting control and a second sorting control, and the device also includes a sorting module, which is configured to: when a trigger operation for the first sorting control is detected, display the molecular conformations in the molecular conformation list in a first order, wherein the first order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from high to low; when a trigger operation for the second sorting control is detected, display the molecular conformations in the molecular conformation list in a second order, wherein the second order is the molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from low to high; and / or, the device also includes an adjustment module, which is configured to: when an adjustment operation for a position in the receptor or the molecular conformation in the three-dimensional structure diagram is detected, display the three-dimensional structure diagram with the position as the center; and / or, when a rotation operation for the three-dimensional structure diagram is detected, rotate the three-dimensional structure diagram; and / or, when a zoom operation for the three-dimensional structure diagram is detected, enlarge or reduce the display size of the three-dimensional structure diagram.In this way, when too many conformations are displayed in the three-dimensional structure diagram, it is difficult to determine the number of displayed conformations with the naked eye. The conformation display prompt can help users intuitively understand the number of currently displayed conformations; and / or, by setting the screening status prompt corresponding to each ligand, it is possible to intuitively distinguish the ligands that have completed the conformational screening from the ligands that have not completed the conformational screening, so that users can select suitable ligands for screening in the secondary conformational screening without re-screening all ligands of the entire target project, which helps to save computing resources while improving the flexibility of conformational screening; and / or, by setting the collection control, it is convenient for users to collect suitable ligands, which helps to quickly obtain the historically collected conformations when viewing the result interface next time; And / or, in this way, by setting the first sorting control and the second sorting control, the sorting of each molecular conformation can be quickly achieved to meet the browsing needs of the user, which is helpful for the user to screen out suitable molecular conformations and is simple to operate; and / or, when faced with a larger three-dimensional structure diagram, the structure that needs to be further viewed can be quickly positioned to the center of the display area through such adjustment operations, thereby facilitating the user to continue to enlarge the three-dimensional structure diagram to meet viewing needs; and / or, by detecting the rotation operation of the three-dimensional structure diagram, the user's need to rotate the three-dimensional structure diagram can be responded to in a timely manner; and / or, by detecting the zoom operation of the three-dimensional structure diagram, the user's need to zoom the three-dimensional structure diagram can be responded to in a timely manner.

[0085] In some embodiments, the functions or modules included in the molecular conformation display device provided in the embodiments of the present disclosure can be used to execute the method described in the above method embodiment. The specific implementation can refer to the description of the above molecular conformation display method embodiment. For the sake of brevity, it will not be repeated here.

[0086] The present disclosure also provides a computer-readable storage medium having computer program instructions stored thereon, which implement the above-mentioned method for displaying molecular conformations when the computer program instructions are executed by a processor. The computer-readable storage medium may be a volatile or non-volatile computer-readable storage medium. In some embodiments, the functions or modules included in the computer-readable storage medium provided in the present disclosure may be used to execute the method described in the above method embodiment, and its specific implementation may refer to the description of the above molecular conformation display method embodiment, and for the sake of brevity, it will not be repeated here.

[0087] The present disclosure also provides an electronic device, comprising: a processor; a memory for storing instructions executable by the processor; wherein the processor is configured to implement the above-mentioned method for displaying molecular conformations when executing the instructions stored in the memory. In some embodiments, the functions or modules included in the electronic device provided by the present disclosure can be used to execute the method described in the above method embodiment, and its specific implementation can refer to the description of the above molecular conformation display method embodiment, and for the sake of brevity, it will not be repeated here.

[0088] The embodiments of the present disclosure also provide a computer program product, including a computer-readable code, or a non-volatile computer-readable storage medium carrying the computer-readable code, and when the computer-readable code is executed in a processor of an electronic device, the processor in the electronic device executes the above-mentioned method for displaying molecular conformations. In some embodiments, the functions or modules included in the computer program product provided by the embodiments of the present disclosure can be used to execute the method described in the above method embodiment, and its specific implementation can refer to the description of the above molecular conformation display method embodiment, and for the sake of brevity, it will not be repeated here.

[0089] Fig.15 1900 is a block diagram showing a method for displaying a molecular conformation according to an embodiment of the present disclosure. For example, the apparatus 1900 may be provided as a server or a terminal device. Fig.15 , the apparatus 1900 includes a processing component 1922, which further includes one or more processors, and a memory resource represented by a memory 1932 for storing instructions, such as an application, that can be executed by the processing component 1922. The application stored in the memory 1932 may include one or more modules, each corresponding to a set of instructions. In addition, the processing component 1922 is configured to execute instructions to perform the above method.

[0090] The device 1900 may also include a power supply component 1926 configured to perform power management of the device 1900, a wired or wireless network interface 1950 configured to connect the device 1900 to a network, and an input / output interface 1958 (I / O interface). The device 1900 may operate based on an operating system stored in the memory 1932, such as Windows Server 2000. TM , MacOS X TM , Unix TM ,Linux TM , FreeBSD TM or similar.

[0091] In an exemplary embodiment, a non-volatile computer-readable storage medium is also provided, such as a memory 1932 including computer program instructions, which can be executed by the processing component 1922 of the device 1900 to perform the above method.

[0092] The present disclosure may be a system, a method and / or a computer program product. The computer program product may include a computer-readable storage medium carrying computer-readable program instructions for causing a processor to implement various aspects of the present disclosure.

[0093] A computer-readable storage medium may be a tangible device that can hold and store instructions used by an instruction execution device. A computer-readable storage medium may be, for example, but not limited to, an electrical storage device, a magnetic storage device, an optical storage device, an electromagnetic storage device, a semiconductor storage device, or any suitable combination of the foregoing. More specific examples of computer-readable storage media (a non-exhaustive list) include: a portable computer disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), a static random access memory (SRAM), a portable compact disk read-only memory (CD-ROM), a digital versatile disk (DVD), a memory stick, a floppy disk, a mechanical encoding device, such as a punch card or a raised structure in a groove on which instructions are stored, and any suitable combination of the foregoing. As used herein, a computer-readable storage medium is not to be interpreted as a transient signal per se, such as a radio wave or other freely propagating electromagnetic wave, an electromagnetic wave propagating through a waveguide or other transmission medium (e.g., a light pulse through a fiber optic cable), or an electrical signal transmitted through a wire.

[0094] The computer-readable program instructions described herein can be downloaded from a computer-readable storage medium to each computing / processing device, or downloaded to an external computer or external storage device via a network, such as the Internet, a local area network, a wide area network, and / or a wireless network. The network can include copper transmission cables, optical fiber transmissions, wireless transmissions, routers, firewalls, switches, gateway computers, and / or edge servers. The network adapter card or network interface in each computing / processing device receives the computer-readable program instructions from the network and forwards the computer-readable program instructions for storage in the computer-readable storage medium in each computing / processing device.

[0095] The computer program instructions for performing the operation of the present disclosure may be assembly instructions, instruction set architecture (ISA) instructions, machine instructions, machine-related instructions, microcode, firmware instructions, state setting data, or source code or object code written in any combination of one or more programming languages, including object-oriented programming languages, such as Smalltalk, C++, etc., and conventional procedural programming languages, such as "C" language or similar programming languages. Computer-readable program instructions may be executed completely on a user's computer, partially on a user's computer, as an independent software package, partially on a user's computer, partially on a remote computer, or completely on a remote computer or server. In the case of a remote computer, the remote computer may be connected to the user's computer via any type of network, including a local area network (LAN) or a wide area network (WAN), or may be connected to an external computer (e.g., using an Internet service provider to connect via the Internet). In some embodiments, an electronic circuit, such as a programmable logic circuit, a field programmable gate array (FPGA), or a programmable logic array (PLA), may be customized by utilizing the state information of the computer-readable program instructions, and the electronic circuit may execute the computer-readable program instructions, thereby realizing various aspects of the present disclosure.

[0096] Various aspects of the present disclosure are described herein with reference to the flowcharts and / or block diagrams of the methods, devices (systems) and computer program products according to the embodiments of the present disclosure. It should be understood that each box in the flowchart and / or block diagram and the combination of each box in the flowchart and / or block diagram can be implemented by computer-readable program instructions.

[0097] These computer-readable program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, or other programmable data processing device, thereby producing a machine, so that when these instructions are executed by the processor of the computer or other programmable data processing device, a device that implements the functions / actions specified in one or more boxes in the flowchart and / or block diagram is generated. These computer-readable program instructions can also be stored in a computer-readable storage medium, and these instructions cause the computer, programmable data processing device, and / or other equipment to work in a specific manner, so that the computer-readable medium storing the instructions includes a manufactured product, which includes instructions for implementing various aspects of the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0098] Computer-readable program instructions may also be loaded onto a computer, other programmable data processing apparatus, or other device so that a series of operating steps are performed on the computer, other programmable data processing apparatus, or other device to produce a computer-implemented process, thereby causing the instructions executed on the computer, other programmable data processing apparatus, or other device to implement the functions / actions specified in one or more boxes in the flowchart and / or block diagram.

[0099] The flow chart and block diagram in the accompanying drawings show the possible architecture, function and operation of the system, method and computer program product according to multiple embodiments of the present disclosure. In this regard, each square box in the flow chart or block diagram can represent a part of a module, program segment or instruction, and a part of the module, program segment or instruction includes one or more executable instructions for realizing the specified logical function. In some alternative implementations, the function marked in the square box can also occur in a sequence different from that marked in the accompanying drawings. For example, two continuous square boxes can actually be executed substantially in parallel, and they can sometimes be executed in reverse order, depending on the functions involved. It should also be noted that each square box in the block diagram and / or flow chart, and the combination of the square boxes in the block diagram and / or flow chart can be implemented with a dedicated hardware-based system that performs the specified function or action, or can be implemented with a combination of special hardware and computer instructions.

[0100] The embodiments of the present disclosure have been described above, and the above description is exemplary, not exhaustive, and is not limited to the disclosed embodiments. Many modifications and changes will be apparent to those of ordinary skill in the art without departing from the scope and spirit of the described embodiments. The selection of terms used herein is intended to best explain the principles of the embodiments, practical applications, or technical improvements in the market, or to enable other persons of ordinary skill in the art to understand the embodiments disclosed herein.

Claims

1. A method for displaying a molecular conformation, characterized in that: include: In the case where a trigger operation of a start control for a target item is detected, conformational screening of a plurality of ligands for the target item is performed based on a calculation input to obtain screening results for the plurality of ligands, the screening results comprising a plurality of molecular conformations; Based on the screening results for the multiple ligands, a result interface is displayed, wherein the result interface displays a ligand list and a three-dimensional structure diagram, wherein the ligand list displays the multiple ligands, and the three-dimensional structure diagram displays a receptor, a default display conformation of a first ligand, and a relative positional relationship between the receptor and the default display conformation of the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list; When a second ligand different from the first ligand is determined from the ligand list according to the ligand selection operation, the default display conformation of the second ligand, the relative position relationship between the default display conformation of the second ligand and the receptor, and the relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand are added to the three-dimensional structure diagram.

2. The method according to claim 1, characterized in that The method further comprises: In case a trigger operation for a conformational screening control is detected, an initial interface for conformational screening is displayed, wherein at least one selectable item is displayed in the initial interface; In the case where the target project is determined from the at least one selectable project according to the project selection operation, a calculation input prompt for the target project is displayed, wherein the calculation input prompt displays a plurality of first input boxes and the start control, and different first input boxes are used to input different calculation inputs, wherein the calculation input includes at least one of a structure file recording and describing the ligand and screening data used for screening; According to the detected input operation for each of the calculation input boxes, the determined calculation input for the target item is displayed in the calculation input prompt, so that the conformation screening is performed based on the calculation input when the start control is triggered.

3. The method according to claim 2, characterized in that The method further comprises: In the case of detecting a trigger operation for an input editing control displayed in the result interface, displaying an optional input prompt for the target item, wherein the optional input prompt displays a plurality of second input boxes and the start control, and different second input boxes are used to input different optional inputs, and the optional inputs include at least one of the general data used for the conformational screening, molecule preparation data, molecular conformation generation data, molecule alignment data, grid generation data, molecule alignment scoring data, and result analysis data; According to the detected input operation for each second input box, the determined optional input for the target item is displayed in the optional input prompt, so as to perform the conformation screening based on the calculated input and the optional input when the start control is triggered.

4. The method according to claim 3, characterized in that The general data includes the calculation mode used for molecular docking, and / or the molecular preparation data includes at least one of data indicating a prefix of a ligand name and data indicating a method of using a ligand, and / or the molecular conformation generation data includes at least one of the number of molecular conformations created, an energy threshold of the molecular conformation, data for indicating stereocenter information, and a root mean square threshold of the molecular conformation, and / or the molecular alignment data includes data indicating an alignment method of the molecular conformation, data indicating a method of searching for the largest common substructure, a timeout for searching for the largest common substructure, data indicating information on the presence of hydrogen atoms in the largest common substructure, and a start time for searching. At least one of the following data is included: a threshold for finding the largest common substructure, data representing complete matching information of a ring, data representing valence matching information, data representing matching information between rings, data representing an atom comparison method, and data representing a chemical bond comparison method, and / or the grid generation data includes the distance between grid points, and / or the molecular alignment scoring data includes at least one of data representing hydrogen atom reading information, the number of generated molecular conformations, the distance between grid points, data representing flexibility information of a receptor, and data representing configuration information of molecular alignment, and / or the result analysis data includes data representing the calculation of molecular standard errors.

5. The method according to claim 1, characterized in that The result interface includes a first area and a second area, the first area includes a plurality of sub-areas, each of the sub-areas displays a corresponding ligand and conformation browsing control, and the second area displays the three-dimensional structure diagram, and the method further includes: When a trigger operation is detected for the conformation browsing control, the third ligand corresponding to the conformation browsing control is determined, and a molecular conformation list for the third ligand is displayed based on the screening result for the third ligand, wherein the molecular conformation list displays description information of each molecular conformation of the third ligand, and the description information includes at least one of a conformation name, a conformation score, and a conformation configuration.

6. The method according to claim 5, characterized in that The method further comprises: When the first molecular conformation is determined from the molecular conformation list according to the conformation selection operation, the first molecular conformation and the relative position relationship between the receptor and the first molecular conformation are displayed in the three-dimensional structure diagram, wherein the first molecular conformation is one of the molecular conformations of the third ligand corresponding to the molecular conformation list.

7. The method according to claim 5, characterized in that Each of the sub-regions also displays a conformation display prompt of the corresponding ligand, and the conformation display prompt includes the total number of molecular conformations of the ligand and the number of molecular conformations displayed in the three-dimensional structure diagram. The method further includes: when it is detected that the number of molecular conformations of the same ligand displayed in the three-dimensional structure diagram has changed, updating the number of molecular conformations of the ligand displayed in the three-dimensional structure diagram, and highlighting the latest conformation display prompt in the sub-region corresponding to the ligand; and / or, Each of the sub-areas also displays a screening status prompt of the corresponding ligand, and the screening status prompt has different first and second states, wherein the screening status prompt in the first state indicates that the ligand has completed the conformational screening, and the screening status prompt in the second state indicates that the ligand has not undergone the conformational screening; and / or, The molecular conformation list also displays a collection control for each molecular conformation, and the method further includes: when a trigger operation for the collection control is detected, using the molecular conformation corresponding to the collection control as the default display conformation of the corresponding ligand; and / or, The molecular conformation list also displays a first sorting control and a second sorting control, and the method further includes: in the case of detecting a trigger operation for the first sorting control, displaying each molecular conformation in the molecular conformation list in a first order, wherein the first order is a molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from high to low; in the case of detecting a trigger operation for the second sorting control, displaying each molecular conformation in the molecular conformation list in a second order, wherein the second order is a molecular conformation order determined by sorting all the molecular conformations in the molecular conformation list from low to high; and / or, The method also includes: when an adjustment operation is detected for a position in the receptor or the molecular conformation in the three-dimensional structure diagram, displaying the three-dimensional structure diagram with the position as the center; and / or, when a rotation operation is detected for the three-dimensional structure diagram, rotating the three-dimensional structure diagram; and / or, when a zoom operation is detected for the three-dimensional structure diagram, enlarging or reducing the display size of the three-dimensional structure diagram.

8. A molecular conformation display device, characterized in that: include: A conformation screening module, wherein the conformation screening module is configured to, when a triggering operation of a start control for a target item is detected, perform conformation screening of a plurality of ligands for the target item based on a calculation input, and obtain screening results for the plurality of ligands, wherein the screening results include a plurality of molecular conformations; A first display module, wherein the first display module is configured to display a result interface based on the screening results for the multiple ligands, wherein the result interface displays a ligand list and a three-dimensional structure diagram, wherein the ligand list displays the multiple ligands, and the three-dimensional structure diagram displays a receptor, a default display conformation of a first ligand, and a relative positional relationship between the receptor and the default display conformation of the first ligand, wherein the first ligand is a ligand that is prominently displayed among the multiple ligands displayed in the ligand list; A second display module, wherein the second display module is configured to, when a second ligand different from the first ligand is determined from the ligand list according to a ligand selection operation, add a default display conformation of the second ligand, a relative position relationship between the default display conformation of the second ligand and the receptor, and a relative position relationship between the default display conformation of the second ligand and the default display conformation of the first ligand to the three-dimensional structure diagram.

9. A molecular conformation display device, characterized in that: include: processor; a memory for storing processor-executable instructions; The processor is configured to implement the method described in any one of claims 1 to 7 when executing the instructions stored in the memory.

10. A non-volatile computer-readable storage medium having computer program instructions stored thereon, characterized in that: When the computer program instructions are executed by a processor, the method according to any one of claims 1 to 7 is implemented.